RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 164 filers reported holding RELAY THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $404,394 | -81.0% | 32,197 | -75.1% | 0.18% | -89.3% |
| Q1 2023 | $2,128,665 | -19.3% | 129,245 | -26.8% | 1.73% | +10.7% |
| Q4 2022 | $2,637,224 | -29.6% | 176,521 | +5.5% | 1.57% | -26.8% |
| Q3 2022 | $3,744,000 | +97.3% | 167,383 | +47.7% | 2.14% | +86.6% |
| Q2 2022 | $1,898,000 | -7.5% | 113,313 | +65.2% | 1.15% | -12.2% |
| Q1 2022 | $2,053,000 | +45.4% | 68,608 | +49.2% | 1.30% | +16.1% |
| Q4 2021 | $1,412,000 | +18.7% | 45,992 | +21.9% | 1.12% | +42.8% |
| Q3 2021 | $1,190,000 | +39.8% | 37,743 | +62.3% | 0.79% | +30.3% |
| Q2 2021 | $851,000 | +46.0% | 23,250 | +37.8% | 0.60% | +39.5% |
| Q1 2021 | $583,000 | -6.3% | 16,876 | +12.7% | 0.43% | +9.1% |
| Q4 2020 | $622,000 | – | 14,975 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 183,112 | $5,665,000 | 3.48% |
| Casdin Capital, LLC | 3,668,574 | $115,670,000 | 2.88% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $879,843,000 | 2.73% |
| BVF INC/IL | 2,049,113 | $64,609,000 | 2.52% |
| Fernwood Investment Management, LLC | 185,063 | $5,835,000 | 2.00% |
| EcoR1 Capital, LLC | 1,385,276 | $43,678,000 | 1.52% |
| Boxer Capital, LLC | 1,294,132 | $40,804,000 | 1.42% |
| Integral Health Asset Management, LLC | 140,000 | $4,414,000 | 1.27% |
| Alphabet Inc. | 1,641,497 | $51,756,000 | 1.23% |
| Bellevue Group AG | 3,755,962 | $118,426,000 | 1.20% |